BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 26, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 9, 2018
View Archived Issues
OHM Oncology acquires rights to Aptose's APL-581 and related molecules
Read More
MaaT Pharma receives authorization to launch European phase II study in severe GvHD
Read More
JW Therapeutics completes series A financing
Read More
Corvus commences public offering of common stock
Read More
TGV Therapeutics and NIH to collaborate on development of novel antifungal agent
Read More
Bioverativ now fully owned subsidiary of Sanofi
Read More
Aeglea Biotherapeutics provides update on clinical trials of pegzilarginase
Read More
Loss of USP28 shown to confer poorer overall survival to melanoma patients
Read More
Pivotal phase III GLOBE study of VB-111 does not meet primary endpoint
Read More
Prokaryotics awarded NIAID grant to support antibiotic program
Read More
FDA accepts NDA for TX-001-HR
Read More
Caladrius Biosciences announces interim results from phase II trial of CLBS-03 in type 1 diabetes
Read More
CPI-1205 well tolerated in B-cell lymphoma trial
Read More
MyoKardia reports Cohort B data from phase II PIONEER-HCM study of mavacamten
Read More
Arsanis Biosciences, Max-Planck-Gesellschaft patent antibodies targeting K. pneumoniae
Read More
Menarini submits MAA in Europe for delafloxacin
Read More
Medical Prognosis Institute and Oncology Venture Sweden propose merger
Read More
Novel compounds for treating HIV infection identified at Gilead
Read More
Pfizer reports positive outcome of FDA committee meeting on tofacitinib for ulcerative colitis
Read More
Henry Ford Health System presents therapeutic mammalian exosomes
Read More
Senhwa Biosciences presents phase I data for CX-5461 in patients with solid tumors
Read More
Cigna to acquire Express Scripts
Read More
Anti-EGFR AVID-100 well tolerated in phase I trial
Read More